Shuttle Pharmaceuticals Holdings (SHPH) is trading down at $4.01 (-3.84%), as of the latest quote. It operates in the Health Care sector.
| FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|
| Income statement | |||||
| Operating income | −$1.74M | −$2.34M | −$5.89M | −$7.70M | −$11.9M |
| Net income | −$1.15M | −$5.00M | −$6.59M | −$9.14M | −$11.7M |
| EPS (diluted) | — | −$1260.00 | −$882.50 | −$826.00 | −$71.60 |
| Balance sheet | |||||
| Cash and equivalents | $504.7K | $8.42M | $2.58M | $1.92M | $334.0K |
| Total assets | $651.6K | $8.65M | $5.95M | $2.51M | $10.5M |
| Total liabilities | $2.28M | $975.7K | $1.90M | $1.80M | $8.22M |
| Long-term debt | $91.0K | — | — | — | — |
| Shareholders' equity | −$1.76M | $7.68M | $4.06M | $709.2K | $2.25M |
| Cash flow | |||||
| Operating cash flow | −$300.3K | −$2.67M | −$5.58M | −$7.33M | −$9.48M |
| Capital expenditure | — | — | $19.0K | — | — |
| Free cash flow | — | — | −$5.60M | — | — |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$3.05M | −$1.78M | −$2.95M | −$3.91M | −$2.27M | −$2.79M | −$2.22M | −$3.95M |
| Net income | −$3.78M | −$1.60M | −$3.05M | −$3.71M | −$2.35M | −$2.61M | −$2.15M | −$3.15M |
| EPS (diluted) | −$398.30 | $21.00 | −$76.00 | −$32.91 | −$10.50 | $47.81 | −$4.30 | −$3.10 |
| Balance sheet | ||||||||
| Cash and equivalents | $156.7K | $1.92M | $4.51M | $4.82M | $2.09M | $334.0K | $1.09M | $90.2K |
| Total assets | $673.6K | $2.51M | $5.31M | $5.50M | $3.54M | $10.5M | $11.8M | $22.8M |
| Total liabilities | $1.99M | $1.80M | $2.02M | $1.90M | $2.15M | $8.22M | $8.46M | $3.63M |
| Shareholders' equity | −$1.32M | $709.2K | $3.29M | $3.61M | $1.39M | $2.25M | $3.35M | $19.2M |
| Cash flow | ||||||||
| Operating cash flow | −$2.00M | −$2.69M | −$2.53M | −$3.36M | −$2.63M | −$973.0K | −$2.42M | −$567.6K |
From Shuttle Pharmaceuticals Holdings's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning Shuttle Pharmaceuticals Holdings in our feed yet.